You have a valid point, but you could also argue that interacting this way with specialist in the field might help PAR better understand the issues and obstacles to effective treatment, and that the more people in the 'industry' who know about us now, the easier and quicker the uptake will be when it hits the market.
General OA media and info, page-644
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 24.0¢ | 23.5¢ | $58.48K | 245.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 56899 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 158336 | 11 |
View Market Depth
| Last trade - 11.45am 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
23.5¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 24.0¢ | 24.0¢ | 23.5¢ | 46702 | ||
| Last updated 12.02pm 17/06/2024 ? | |||||
| PAR (ASX) Chart |
